APA (7th ed.) Citation

Frontzek, F., Renaud, L., Dührsen, U., Poeschel, V., Bernard, S., Chartier, L., . . . Schmitz, N. (2024). Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration. Leukemia, 38(10), 2225. https://doi.org/10.1038/s41375-024-02371-y

Chicago Style (17th ed.) Citation

Frontzek, Fabian, et al. "Identification, Risk Factors, and Clinical Course of CNS Relapse in DLBCL Patients Across 19 Prospective Phase 2 and 3 Trials—a LYSA and GLA/ DSHNHL Collaboration." Leukemia 38, no. 10 (2024): 2225. https://doi.org/10.1038/s41375-024-02371-y.

MLA (9th ed.) Citation

Frontzek, Fabian, et al. "Identification, Risk Factors, and Clinical Course of CNS Relapse in DLBCL Patients Across 19 Prospective Phase 2 and 3 Trials—a LYSA and GLA/ DSHNHL Collaboration." Leukemia, vol. 38, no. 10, 2024, p. 2225, https://doi.org/10.1038/s41375-024-02371-y.